Navigation Links
Sanofi-aventis Announces Good First-quarter 2009 Performance
Date:4/29/2009

sition of Zentiva and a reduction in net debt from euro 1.8bn to euro 1.2bn
  • Recommendation by the FDA Advisory Committee for approval of Multaq(R)

  • Transformation of sanofi-aventis

    • Significant boost to our generics business, with 2008 proforma net sales of approximately euro 1.2 billion due to the acquisitions of Zentiva, Medley and Kendrick
    • Updating of our R&D portfolio: refocusing on the most promising projects, and acceleration of external R&D alliances
    • Acquisition of BiPar Sciences, Inc., strengthening our oncology R&D portfolio with the addition of the PARP inhibitor BSI-201 and demonstrating our strong commitment in oncology

    2009 Guidance reiterated

    • Sanofi-aventis confirms its expectations for growth in 2009 adjusted EPS excluding selected items of at least 7% at constant exchange rates, barring major adverse events

    (1) Adjusted EPS excluding selected items

    (2) Growth in net sales is expressed at constant exchange rates unless otherwise indicated

    (3) Growth in net sales expressed on a constant structure basis and at constant exchange rates

    First-quarter 2009 sales

    Unless otherwise indicated, all sales growth figures in this press release are stated at constant exchange rates

    Sanofi-aventis generated first-quarter net sales of euro 7,107 million, up 2.5% on a reported basis. Exchange rate movements had a net favorable effect of 2.7 points, reflecting the appreciation of the dollar against the euro, which largely compensated for the negative effect of some other currencies. At constant exchange rates and after taking account of changes in structure (in particular the end of commercialization by sa
    '/>"/>

    SOURCE Sanofi-aventis
    Copyright©2009 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

    Related medicine news :

    1. Sanofi-Aventis and Roche/Chugais Drugs Will Dominate the Indian Colorectal Cancer Drug Market Through 2013
    2. Sanofi-aventis Affirms Its Commitment to Partnering with Local Communities to Improve Hispanic and African American Health
    3. Apidra(R) SoloSTAR(R), the Easy-to-Use Insulin Delivery Device from sanofi-aventis, Now Available in the United States
    4. Paul Chew Appointed to sanofi-aventis U.S. Chief Science Officer/Chief Medical Officer
    5. Sanofi-aventis Partners with the Hispanic Community in Miami to Increase Health Awareness, Access to Resources and Help Improve Patient Care
    6. Sanofi-aventis Partners with the Hispanic Community in San Antonio to Increase Health Awareness, Access to Resources and Help Improve Patient Care
    7. Sanofi-aventis Delivers 2008 Results Above Guidance
    8. Sanofi-aventis Partners with the Hispanic Community in Bronx to Increase Health Awareness, Access to Resources and Help Improve Patient Care
    9. Sanofi-aventis Partners with the African American Community in Memphis to Increase Health Awareness, Access to Resources and Help Improve Patient Care
    10. Sanofi-aventis U.S. Announces Increased Access to Drugs for Low Income Patients Through Expanded PAP Programs
    11. Sanofi-aventis Partners with the African American Community in Baltimore to Increase Health Awareness, Access to Resources and Help Improve Patient Care
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:4/14/2014)... orphaned by HIV/AIDS in South Africa may provide insight ... behavior issues in other areas of the world, which ... that could lead to successful interventions. , A ... United Nations mentions that due to the HIV/AIDS pandemic, ... African, children are at an increased risk for mental ...
    (Date:4/14/2014)... A new study shows that moderate to severe ... risk of stroke, cancer and death. , Results of ... to severe obstructive sleep apnea were four times more ... times more likely to have a stroke (HR = ... (HR = 3.4), and 2.5 times more likely to ...
    (Date:4/14/2014)... Dallas study involving serious youth offenders, the answer to one ... seven years: "How long do you think you,ll live?", According ... offending over time., Author Dr. Alex Piquero said the study ... of them offend at very high rates and commit more ... much later in life offend much less., "In a lot ...
    (Date:4/14/2014)... with symptoms increasing dramatically during some of the most important ... has found. , Depressive symptoms increased on average by 68 ... young men, who were around 25 years old when they ... their children. The results of the study were published April ... is the first to identify when young fathers are at ...
    (Date:4/14/2014)... Lower weight babies and babies who aren,t breastfed ... risk of developing chronic inflammation and related health ... study. , "There were good reasons to hypothesize ... inflammation in adulthood," says Thomas McDade (Northwestern University), ... in the Child & Brain Development program. "It ...
    Breaking Medicine News(10 mins):Health News:Researchers identify children with emotional behavior difficulties 2Health News:Researchers identify children with emotional behavior difficulties 3Health News:Study links severe sleep apnea to increased risk of stroke, cancer and death 2Health News:UT Dallas study: Youth who fail to envision future commit more crimes 2Health News:Young dads at high risk of depression, too 2Health News:Low birth weight, less breastfeeding create later health risks 2
    ... 12 /PRNewswire-FirstCall/ - Med-Emerg International Inc.,(OTCBB - MDER), ... three months ended March 31, 2008 were $5.5 ... in 2007 (all amounts are $US unless,otherwise stated). ... interest and taxes (EBITDA) improved to $179K,from a ...
    ... 12 /PRNewswire-FirstCall/ - The Westaim Corporation,announced today that for the ... of $6.9 million or 7 cents per share, on revenues ... recorded a net,loss of $6.7 million, or 7 cents per ... operations was $3.2 million for the quarter,compared to $1.9 million ...
    ... Baptist Health South,Florida Inc., a health care system ... $7,775,000 to settle claims that it violated the,False Claims ... by paying,excessive compensation to an oncology group that was ... the Department of Justice,announced today. The payments were made ...
    ... of Michigan Comprehensive Cancer Center have found a series ... to survive cancers of the base of the tongue ... cancers linked to HPV, or human papillomavirus, are the ... tumors that express high levels of a certain growth ...
    ... ST. LOUIS, May 12 Allied Healthcare Products,Inc. (Nasdaq: ... third,quarter ending March 31 fell 64 percent, from about $278,000 ... the current quarter, or 1 cent per,share., Sales for ... quarter of the prior year. However, higher material and labor ...
    ... 12 Keck Graduate Institute (KGI),today announced that the ... KGI,s first PhD in Applied Life Sciences student, Eric,Tan, ... "We are very excited and proud of Eric,s achievement ... said T. Gregory Dewey, KGI,s senior,vice president for academic ...
    Cached Medicine News:Health News:Med-Emerg International Inc. reports improved income from continuing operations 2Health News:Med-Emerg International Inc. reports improved income from continuing operations 3Health News:Westaim announces 2008 first quarter results 2Health News:Westaim announces 2008 first quarter results 3Health News:Florida Hospital Group Pays U.S. $7,775,000 to Settle False Claims Act Allegations 2Health News:HPV linked to better survival in tonsil, tongue cancer, U-M study finds 2Health News:HPV linked to better survival in tonsil, tongue cancer, U-M study finds 3Health News:Allied Healthcare Net Falls on Manufacturing Delays 2Health News:Allied Healthcare Net Falls on Manufacturing Delays 3Health News:Allied Healthcare Net Falls on Manufacturing Delays 4Health News:Allied Healthcare Net Falls on Manufacturing Delays 5Health News:KGI 2008 Commencement Features First PhD Graduate, Biotech Painting 2
    (Date:1/15/2014)... 2014  Echo Therapeutics, Inc. (Nasdaq: ... its Symphony® CGM System as a non-invasive, wireless ... Robert F. Doman , Executive Chairman and Interim ... Noble Financial Capital Markets, Tenth Annual Equity Conference. ... corporate presentation to prospective corporate partners and investors ...
    (Date:1/15/2014)... Jan. 15, 2014 Reportlinker.com announces ... available in its catalogue: ... Worldwide Analysis http://www.reportlinker.com/p01957812/Insulin-Pump-Market--Forecast-–-Worldwide-Analysis.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_Equipment_and_Supply ... Insulin Pumps are ... insulin delivery systems especially for type 1 ...
    (Date:1/15/2014)... , Jan. 15, 2014 ... report is available in its catalogue: ... for Advanced Drug Delivery Systems -- Focus ... STUDY OBJECTIVES ... the very important aspects in today,s growth ...
    Breaking Medicine Technology:Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 3Insulin Pump Market & Forecast - Worldwide Analysis 2Insulin Pump Market & Forecast - Worldwide Analysis 3Insulin Pump Market & Forecast - Worldwide Analysis 4Insulin Pump Market & Forecast - Worldwide Analysis 5Insulin Pump Market & Forecast - Worldwide Analysis 6Insulin Pump Market & Forecast - Worldwide Analysis 7Insulin Pump Market & Forecast - Worldwide Analysis 8Insulin Pump Market & Forecast - Worldwide Analysis 9Insulin Pump Market & Forecast - Worldwide Analysis 10Insulin Pump Market & Forecast - Worldwide Analysis 11Insulin Pump Market & Forecast - Worldwide Analysis 12Insulin Pump Market & Forecast - Worldwide Analysis 13Insulin Pump Market & Forecast - Worldwide Analysis 14Insulin Pump Market & Forecast - Worldwide Analysis 15Insulin Pump Market & Forecast - Worldwide Analysis 16Insulin Pump Market & Forecast - Worldwide Analysis 17Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 2Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 4Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 5Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 6Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 7Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 8Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 9Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 10Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 11Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 12Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 13Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 14Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 15Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 16Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 17Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 18
    ... , GREAT NECK, N.Y. , July 23 The ... seeking patients with cancer of the oropharynx (back of the mouth) to ... , , ... any previous treatment. Further, their cancer must be unassociated with the human ...
    ... July 23 /PRNewswire-Asia-FirstCall/ -- China Sky One,Medical, Inc. ("China Sky ... integrated pharmaceutical company in the People,s Republic of,China ("PRC"), ... and Drug Administration (SFDA) in China for the production ... , , , ...
    Cached Medicine Technology:Study Seeks Volunteers to Measure Safety of Treatment 'Boost' for Patients with Oropharyngeal Cancer 2China Sky One Medical Obtains SFDA Approval for Ciclopirox Olamine Vaginal Suppositories 2China Sky One Medical Obtains SFDA Approval for Ciclopirox Olamine Vaginal Suppositories 3
    Latex agglutination inhibition slide test for the qualitative detection of hCG in urine....
    Test for the quantitative determination of antideoxyribonuclease-B (ADNase-B) in serum....
    Hemagglutination slide test for the qualitative and quantitative detection of Rheumatoid Factor in serum or synovial fluid....
    Latex agglutination slide test for the qualitative or semi-quantitative detection of infectious mononucleosis heterophile antibodies in serum or plasma....
    Medicine Products: